留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

后疫情时代的肺移植临床研究发展和未来展望

焦国慧 陈静瑜

焦国慧, 陈静瑜. 后疫情时代的肺移植临床研究发展和未来展望[J]. 器官移植, 2021, 12(5): 506-511. doi: 10.3969/j.issn.1674-7445.2021.05.002
引用本文: 焦国慧, 陈静瑜. 后疫情时代的肺移植临床研究发展和未来展望[J]. 器官移植, 2021, 12(5): 506-511. doi: 10.3969/j.issn.1674-7445.2021.05.002
Jiao Guohui, Chen Jingyu. Development and prospect of clinical research on lung transplantation in post-COVID-19 era[J]. ORGAN TRANSPLANTATION, 2021, 12(5): 506-511. doi: 10.3969/j.issn.1674-7445.2021.05.002
Citation: Jiao Guohui, Chen Jingyu. Development and prospect of clinical research on lung transplantation in post-COVID-19 era[J]. ORGAN TRANSPLANTATION, 2021, 12(5): 506-511. doi: 10.3969/j.issn.1674-7445.2021.05.002

后疫情时代的肺移植临床研究发展和未来展望

doi: 10.3969/j.issn.1674-7445.2021.05.002
基金项目: 

国家自然科学基金面上项目 82070059

无锡市新型冠状病毒感染应急防治科技专项项目 N2020X002

详细信息
    作者简介:

    焦国慧,女,1985年生,博士,助理研究员,研究方向为肺移植和临床试验,Email: ghjiao2012@163.com

    陈静瑜,南京医科大学二级教授、博士研究生导师,国务院突出贡献获得者。现任南京医科大学附属无锡人民医院、无锡市器官移植研究院院长,江苏省肺移植中心主任,浙江大学医学院附属第二医院副院长。兼任中国人体器官捐献与移植委员会委员、中国肺移植联盟执行主席、中华医学会器官移植学分会常务委员、国家肺移植组组长、国家卫生健康委员会肺移植数据管理单位负责人、国家肺移植质控中心主任。兼任《器官移植》杂志常务编委。擅长肺部疾病的诊断治疗,肺移植、胸腔镜手术、肺癌扩大根治、肺癌的综合治疗及体外膜肺氧合(ECMO)应用。自2002年至今完成肺移植1 200多例,兼任北京、无锡两个肺移植团队主任,两个中心年肺移植量均超百例,均入选全球八大肺移植中心。推动了中国器官转运绿色通道的建立,2020年2月完成全球首例新型冠状病毒肺炎(新冠肺炎)双肺移植,4月份担任国家肺移植组组长赴武汉主持开展新冠肺炎肺移植。主办十届全国心肺移植学习班曁研讨会、首届中国国际肺移植论坛。发表有关肺移植的中文核心论文130多篇,SCI论文40余篇,主持编写专著3部。主持国家十一五攻关项目1项,完成国家卫生部课题1项和江苏省卫生厅课题2项。扶持国家18个省30多家医院开展了肺移植。获得华夏医学科技奖一等奖、中华医学奖二等奖、江苏省科技奖三等奖、教育部科技奖一等奖,先后荣获全国五一劳动奖章、全国先进工作者,连任三届全国人大代表。2010年获得国务院政府特殊津贴,2017年入选“国家卫计委突出贡献中青年专家”、2020年获中国医师奖和“全国抗击新冠肺炎疫情先进个人”荣誉称号

    通讯作者:

    陈静瑜,E-mail: chenjy@wuxiph.com

  • 中图分类号: R617, R563

Development and prospect of clinical research on lung transplantation in post-COVID-19 era

More Information
  • 摘要: 肺移植技术在全球经历了近半个世纪的发展,在中国也高速发展了二十余年,中国肺移植逐渐融入国际肺移植大家庭。2020年新型冠状病毒肺炎(新冠肺炎)疫情暴发,既是对中国肺移植发展的挑战,也使得全球同行关注中国肺移植发展,加速了国际间的交流与合作。随着对新冠肺炎重症患者肺移植的临床和基础研究逐步深入,移植科医师对于未来中国肺移植在供者的维护、高龄和儿童受者的选择、围手术期管理等方面有了更多的认知和思考。对于肺移植相关学科交叉领域的研究,需要开展设计优良、多方协作的临床试验,不断推进学科理论和实践的创新。

     

  • [1] CHEN JY, QIAO K, LIU F, et al. Lung transplantation as therapeutic option in acute respiratory distress syndrome for coronavirus disease 2019-related pulmonary fibrosis[J]. Chin Med J (Engl), 2020, 133(12): 1390-1396. DOI: 10.1097/CM9.0000000000000839.
    [2] LUO WR, YU H, GOU JZ, et al. Histopathologic findings in the explant lungs of a patient with COVID-19 treated with bilateral orthotopic lung transplant[J]. Transplantation, 2020, 104(11): e329-e331. DOI: 10.1097/TP.0000000000003412.
    [3] CHEN XJ, LI K, XU L, et al. Novel insight from the first lung transplant of a COVID-19 patient[J]. Eur J Clin Invest, 2021, 51(1): e13443. DOI: 10.1111/eci.13443.
    [4] HAN W, ZHU M, CHEN J, et al. Lung transplantation for elderly patients with end-stage COVID-19 pneumonia[J]. Ann Surg, 2020, 272(1): e33-e34. DOI: 10.1097/SLA. 0000000000003955.
    [5] WU B, HUANG M, JIAO G, et al. Lung transplantation during the outbreak of coronavirus disease 2019 in China[J]. J Thorac Cardiovasc Surg, 2020, DOI: 10.1016/j.jtcvs.2020.10.154[Epubahead of print].
    [6] WANG Y, YANG H, LIU H, et al. Strategies to halt 2019 novel coronavirus (SARS-CoV-2) spread for organ transplantation programs at the Sichuan Academy of Medical Science and Sichuan Provincial People's Hospital, China[J]. Am J Transplant, 2020, 20(7): 1837-1839. DOI: 10.1111/ajt.15972.
    [7] SUN Q, QIU H, HUANG M, et al. Lower mortality of COVID-19 by early recognition and intervention: experience from Jiangsu Province[J]. Ann Intensive Care, 2020, 10(1): 33. DOI: 10.1186/s13613-020-00650-2.
    [8] HAWKINS RB, MEHAFFEY JH, CHARLES EJ, et al. Lung transplantation for severe post-coronavirus disease 2019 respiratory failure[J]. Transplantation, 2021, 105(6): 1381-1387. DOI: 10.1097/TP.0000000000003706.
    [9] XUAN TM, WANG XX, PU XY, et al. Primary percutaneous coronary intervention in a COVID-19 patient with ST-segment elevation myocardial infarction after lung transplantation: a case report[J]. J Zhejiang Univ Sci B, 2020, 21(5): 411-415. DOI: 10.1631/jzus.B2000182.
    [10] CHEN J, WU H, YU Y, et al. Pulmonary alveolar regeneration in adult COVID-19 patients[J]. Cell Res, 2020, 30(8): 708-710. DOI: 10.1038/s41422-020-0369-7.
    [11] 陈英伦, 卫栋, 王梓涛, 等. IL-10改善心脏死亡大鼠离体肺灌注后供肺功能的实验研究[J]. 器官移植, 2021, 12(4): 421-427. DOI: 10.3969/j.issn.1674-7445. 2021.04.008.

    CHEN YL, WEI D, WANG ZT, et al. Experimental study on the role of IL-10 in improving donor lung function after ex vivo lung perfusion in rats of cardiac death[J]. Organ Transplant, 2021, 12(4): 421-427. DOI: 10.3969/j.issn.1674-7445.2021.04.008.
    [12] LI XS, HU CX, LIU F, et al. Green channel of human organ transport improved the utilization rate of Chinese citizens' donated lungs: a single-center data analysis[J]. Chin Med J (Engl), 2021, 134(2): 222-224. DOI: 10.1097/CM9.0000000000001325.
    [13] HUANG J, TIAN D, CHEN J. A modified lobar transplants combining RUL and RML for small recipients[J]. Ann Thorac Surg, 2021, DOI: 10.1016/j.athoracsur.2021.03.080[Epubahead of print].
    [14] YUE B, WU B, ZHANG J, et al. Pediatric lung transplantation in the largest lung transplantation center of China: embarking on a long road[J]. Sci Rep, 2020, 10(1): 12471. DOI: 10.1038/s41598-020-69340-0.
    [15] VALAPOUR M, LEHR CJ, SKEANS MA, et al. OPTN/SRTR 2017 annual data report: lung[J]. Am J Transplant, 2019, 19 (Suppl 2): 404-484. DOI: 10.1111/ajt.15279.
    [16] COSTELLO JP, CARVAJAL HG, ABARBANELL AM, et al. Surgical considerations in infant lung transplantation: challenges and opportunities[J]. Am J Transplant, 2021, 21(1): 15-20. DOI: 10.1111/ajt.16282.
    [17] BLUME ED, VANDERPLUYM C, LORTS A, et al. Second annual Pediatric Interagency Registry for Mechanical Circulatory Support (Pedimacs) report: pre-implant characteristics and outcomes[J]. J Heart Lung Transplant, 2018, 37(1): 38-45. DOI: 10.1016/j.healun.2017.06.017.
    [18] DE LUCA D, TISSIERES P, KNEYBER MCJ, et al. Lung transplantation in neonates and infants: ESPNIC survey of European neonatologists and pediatric intensivists[J]. Eur J Pediatr, 2021, 180(1): 295-298. DOI: 10.1007/s00431-020-03742-0.
    [19] SCHWEIGER T, HOETZENECKER K. Is chronological age still a hard selection criterion for lung transplantation?[J]. J Heart Lung Transplant, 2021, 40(2): 99-100. DOI: 10.1016/j.healun.2020.11.011.
    [20] LEHR CJ, BLACKSTONE EH, MCCURRY KR, et al. Extremes of age decrease survival in adults after lung transplant[J]. Chest, 2020, 157(4): 907-915. DOI: 10.1016/j.chest.2019.06.042.
    [21] MOSHER CL, WEBER JM, FRANKEL CW, et al. Risk factors for mortality in lung transplant recipients aged ≥65 years: a retrospective cohort study of 5, 815 patients in the Scientific Registry of Transplant Recipients[J]. J Heart Lung Transplant, 2021, 40(1): 42-55. DOI: 10.1016/j.healun.2020.10.009.
    [22] PENG G, YANG C, LIU M, et al. Pulmonary fibrosis combined with lung cancer following lung transplantation: should we do more?[J]. Transl Lung Cancer Res, 2021, 10(3): 1588-1593. DOI: 10.21037/tlcr-21-46.
    [23] HU CX, CHEN WH, HE JX, et al. Lung transplantation in China between 2015 and 2018[J]. Chin Med J (Engl), 2019, 132(23): 2783-2789. DOI: 10.1097/CM9.00000000 00000543.
    [24] COMBS MP, WHEELER DS, LUTH JE, et al. Lung microbiota predict chronic rejection in healthy lung transplant recipients: a prospective cohort study[J]. Lancet Respir Med, 2021, 9(6): 601-612. DOI: 10.1016/S2213-2600(20)30405-7.
    [25] GRASSELLI G, SCARAVILLI V, ALAGNA L, et al. Gastrointestinal colonization with multidrug-resistant Gram-negative bacteria during extracorporeal membrane oxygenation: effect on the risk of subsequent infections and impact on patient outcome[J]. Ann Intensive Care, 2019, 9(1): 141. DOI: 10.1186/s13613-019-0615-7.
    [26] TIAN D, SHⅡYA H, SATO M, et al. Rat lung transplantation model: modifications of the cuff technique[J]. Ann Transl Med, 2020, 8(6): 407. DOI: 10.21037/atm.2020.02.46.
    [27] WU H, YU Y, HUANG H, et al. Progressive pulmonary fibrosis is caused by elevated mechanical tension on alveolar stem cells[J]. Cell, 2020, 180(1): 107-121. DOI: 10.1016/j.cell.2019.11.027.
    [28] YUAN Q, BASIT A, LIANG W, et al. Pazopanib ameliorates acute lung injuries via inhibition of MAP3K2 and MAP3K3[J]. Sci Transl Med, 2021, 13(591): eabc2499. DOI: 10.1126/scitranslmed.abc2499.
    [29] SWOL J, SHIGEMURA N, ICHIBA S, et al. Artificial lungs--where are we going with the lung replacement therapy?[J]. Artif Organs, 2020, 44(11): 1135-1149. DOI: 10.1111/aor.13801.
  • 加载中
图(1)
计量
  • 文章访问数:  288
  • HTML全文浏览量:  76
  • PDF下载量:  71
  • 被引次数: 0
出版历程
  • 收稿日期:  2021-06-15
  • 网络出版日期:  2021-09-15
  • 刊出日期:  2021-09-15

目录

    /

    返回文章
    返回